Organ donor screening for infectious diseases: Review of practice and implications for transplantation

Transplantation

Volumn 65, Issue 5, 1998, Pages 603-610

  Delmonico, Francis L ^a,b   Snydman, David R ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New England Organ Bank   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIGEN P24; CEPHALOSPORIN; COTRIMOXAZOLE; CYTOMEGALOVIRUS ANTIBODY; DOXYCYCLINE; ERYTHROMYCIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PENICILLIN G; PROTOZOON ANTIBODY; TETRACYCLINE; VIRUS DNA;

BACTEREMIA; CYTOMEGALOVIRUS INFECTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; LATEX AGGLUTINATION TEST; ORGAN DONOR; ORGAN TRANSPLANTATION; POLICY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SEPSIS; SEROLOGY; SYPHILIS; TOXOPLASMOSIS; VIRUS TRANSMISSION;

COMMUNICABLE DISEASES; CYTOMEGALOVIRUS INFECTIONS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HIV INFECTIONS; HTLV-I INFECTIONS; HUMANS; SEROLOGIC TESTS; SYPHILIS; TISSUE DONORS; TOXOPLASMOSIS;

EID: 0032521045     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803150-00001     Document Type: Review

References (73)

1. Organ donation for transplantation. The Medical Letter 1995; 35: 60.
2. Tjabbes H. Donor screening: an overview of current regulation and practices in Europe. Transplant Proc 1996; 28: 2950.
3. Domen R, Nelson K. Results of a survey of infectious disease testing practices by organ procurement organizations in the United States. Transplantation 1997; 63: 1790.
4. Rubin R, Jenkins R, Shaw B, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987; 44: 1.
5. Quarto M, Germinario C, Fontana A, Barbuti S. HIV transmission through kidney transplantation from a living related donor. N Engl J Med 1989; 320: 1754.
6. Centers for Disease Control. U.S. Public Health Service guidelines for testing and counseling blood and plasma donors for human immunodeficiency virus type 1 antigen. Morb Mort Wkly Rep 1996; 45: 1.
7. Diagnostic tests for HIV. The Medical Letter 1997; 39: 81.
8. Simonds R, Holmberg S, Hurwitz R, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726.
9. Centers for Disease Control. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Morb Mort Wkly Rep 1994; 43: 1.
10. Centers for Disease Control. Clarification of human immunodeficiency virus screening practices for organ donation. Fed Register 1996; 61: 56548.
11. Sullivan M, Williams A, Fang C, Grandinetti T, Poiesz B, Ehrlich G. Transmission of human T-lymphotropic virus types I and II by blood transfusion. Arch Intern Med 1991; 151: 2043.
12. Dodd R. The risk of transfusion transmitted infection. N Engl J Med 1992; 327: 419.
13. Lutwick L, Sywassink J, Corry RJ, Shorey J. The transmission of hepatitis B by renal transplantation. Clin Nephrol 1983; 19: 317.
14. Wolf J, Perkins H, Schreeder M, Vincenti F. The transplanted kidney as a source of hepatitis B infection. Ann Intern Med 1979; 91: 412.
15. Gonzalez-Peralta R, Andres J, Tung F, et al. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient. Transplantation 1994; 58: 114.
16. Chan P, Lok A, Cheng I, Chan M. The impact of donor and recipient hepatitis B surface antigen status on liver disease and survival in renal transplant recipients. Transplantation 1992; 53: 128.
17. Liang T, Baruch Y, Ben-Porath E, et al. HBV infection in patients with idiopathic liver disease. Hepatology 1991; 13: 1044.
18. Douglas D, Rakela J, Marnish D, Wright T, Krom R, Wiesner R. Transmission of hepatitis B virus (HBV) infection from orthotopic donor livers. Hepatology 1992; 16: 49A.
19. Dickson R, Everhart J. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1996; 110: A1182.
20. Wachs M, Amend W, Ascher N, et al. The risk of transmission of hepatitis B from HBsAg (-), HBcAb (+), HBIgM(-) organ donors. Transplantation 1995; 59: 230.
21. Aldersley M, Eglin R, O'Grady J. Liver transplantation and de novo hepatitis B infection. Lancet 1994; 343: 667.
22. Kadian M, Hawkins L, Nespral J, Schwartz M, Miller C. Use of hepatitis B core antibody positive multiorgan donors. Presented at the Second International Conference of the Society of Organ Sharing. Vancouver, British Columbia, Canada 1993.
23. Donovan J, Schafer D, Goonewardene T, et al. Development of hepatitis B infection after liver transplantation with donor livers from patients with HBcAb. Hepatology 1994; 20: 129A.
24. Radomski J, Moritz M, Armenti V, Munoz S, Smolinski S. Risk of hepatitis B transmission from organ donors who are hepatitis B surface antigen (-) and hepatitis B core antibody (+). Hepatology 1994; 20: 129A.
25. Radomski J, Moritz M, Armenti V, Munoz S. Hepatitis B transmission from a liver donor who tested negative for hepatitis B surface antigen and positive for hepatitis B core antibody. Liver Transplant Surg 1996; 2: 130.
26. Douglas D, Rakela J, Wright T, Krom R, Wiesner R. The clinical course of transplantation-associated de novo Hepatitis B infection in the liver transplant recipient. Liver Transplant Surg 1997; 3: 105.
27. Paletta L. Organ procurement issues related to viral hepatitis. In: Lewis D, McCoy J, eds. Donor management notes, Vol. 2. Publisher: Sally A. Todt, 1996: No. 5, October, p. 1.
28. Satterthwaite R, Ozgu I, Shidban H, et al. Risks of transplanting kidneys from hepatitis b surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation 1997; 64: 432.
29. Cirocco R, Zucker K, Contreras N, et al. The presence of hepatitis B core antibody does not preclude kidney donation. Transplantation 1997; 63: 1702.
30. Turner D, Zuckerman M, Alexander G, Waite J, Wreghitt T. Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing. Transplantation 1997; 63: 775.
31. Caldwell S. Hard times and imperfect organs. Liver Transplant Surg 1997; 3: 181.
32. Pereira B, Levey A. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997; 51: 981.
33. Pereira B, Wright T, Schmid C, et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. Kidney Int 1994; 46: 868.
34. Fishman J, Rubin R, Koziel M, Periera B. Hepatitis C virus and organ transplantation. Transplantation 1996; 62: 147.
35. Pereira B, Milford E, Kirkman R, Levey A. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 454.
36. Lake K, Smith C, LaForest S, Allen J, Prtizker M, Emery R. Policies regarding the transplantation of hepatitis C-positive candidates and donor organs. J Heart Lung Transplant 1997; 16: 17.
37. Ciancio G, Burke G, Roth D, Zucker K, Tzakis A, Miller J. The significance of infections in donor organs. Transplant Immunol 1996; 12: 3.
38. Miller J, Roth D, Schiff E. Hepatitis C and organ transplantation. N Engl J Med 1993; 328: 312.
39. Widell A, Mansson S, Persson T, Thysell M, Hermodssen S, Blohme I. Hepatitis C superinfection in hepatitis C (HCV) infected patients transplanted with an HCV-infected kidney. Transplantation 1995; 60: 642.
40. Farci P, Alter H, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135.
41. Araya V, Rakela J, Wright T. Hepatitis C after orthotopic liver transplantation. Gastroenterology 1997; 112: 575.
42. Kliem V, Van Den Hoff U, Brunkhorst R, et al. The long-term course of hepatitis C after kidney transplantation. Transplantation 1996; 62: 1417.
43. Kirk A, Heisey D, D'Alessandro A, et al. Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys. Transplantation 1996; 62: 1758.
44. Ho M, Suwansirkui S, Dowling J, Youngblood L, Armstrong J. The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 1975; 293: 1109.
45. Chou S. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N Engl J Med 1996; 314: 1418.
46. Bueno J, Green M, Kocoshis S, et al. Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997; 25: 1078.
47. Rubin R. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990; 12 (suppl 7): S754.
48. Ettinger N, Bailey T, Trulock E, et al. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993; 147: 1017.
49. Manez R, Kusne S, Green M, et al. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995; 59: 1010.
50. Falagas M, Arbo M, Ruthazer R, et al. Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients. Transplantation 1997; 63: 1595.
51. George M, Snydman D, Werner B, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Am J Med 1997; 103: 106.
52. Grattan M, Moreno-Cabral C, Starnes V, Oyer P, Stinson E, Shumway N. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
53. Falagas M, Snydman D, Griffith J, Ruthazer R, Werner B. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997; 126: 275.
54. Patel R, Snydman D, Rubin R, et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279.
55. Kasiske B, Ravenscraft M, Ramos E, Gaston R, Bia M, Danovitch G. The evaluation of living renal transplant donors: clinical practice guidelines. J Am Soc Nephrol 1996; 7: 2288.
56. Stagno S, Tinker M, Elrod C, Fuccillo D, Cloud G, O'Beirne A. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol 1985; 21: 930.
57. Demmler G, Six H, Hurst S, Yow M. Enzyme-linked immunosorbent assay for the detection of IgM-class antibodies to cytomegalovirus. J Infect Dis 1986; 153: 1152.
58. Chou S, Kim D, Scott K, Sewell D. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients. J Clin Microbiol 1987; 25: 52.
59. Gottesdiener K. Transplanted infections: donor to host transmission with the allograft. Ann Intern Med 1989; 110: 1001.
60. Gibel L, Sterkling W, Hoy W, Harford A. Is serological evidence of infection with syphilis a contraindication to kidney donation? J Urol 1987; 138: 1226.
61. Orr K, Gould F, Short G, et al. Outcome of toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect 1994; 29: 249.
62. Podzamczer D, Miro J, Bolao F, et al. Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1995; 123: 175.
63. Centers for Disease Control. Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. JAMA 1987; 258: 309.
64. Firlit C, Jonasson O, Kahan B, Bergan J. Reye syndrome cadaveric kidneys. Arch Surg 1974; 109: 797.
65. Richardson C, Warner O, Callender C. Renal transplantation in Reye's syndrome: fate of the recipient: a case report. J Urol 1979; 121: 497.
66. Quagliarello V, Scheld W. Treatment of bacterial meningitis. N Engl J Med 1997; 336: 708.
67. Doig R, Boyd P, Eykyn S. Staphylococcus aureus transmitted in transplanted kidneys. Lancet 1975; 2: 243.
68. Weber T, Freier D, Turcotte J. Transplantation of infected kidneys. Transplantation 1979; 27: 63.
69. Nelson P, Delmonico F, Tolkoff-Rubin N, et al. Unsuspected donor Pseudomonas infection causing arterial disruption after renal transplantation. Transplantation 1984; 37: 313.
70. Berggren H, Berglin E, Kjellman U, Mantovani V, Nilsson B. Successful outcome after massive bleeding in a heart transplant recipient with mycotic aortitis. Scand J Thorac Cardiovasc Surg 1994; 28: 45.
71. Benedetti E, Gruessner A, Troppman C, et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg 1996; 183: 307.
72. Mossad S, Avery R, Goormastic M, Hobbs R, Stewart R. Significance of positive blood cultures from donor left atrium and postpreservation fluid in heart transplantation. Transplantation 1997; 64: 1209.
73. Bonatti A, Konigsrainer A, Allerberg F, Riedmann B, Margreiter R, Steurer W. How to treat graft infection after pancreatic transplantation. Transplant Proc 1995; 27: 3045.